Microvesicles as mediators of intercellular communication in cancer

Methods in Molecular Biology

Volumn 1165, Issue , 2014, Pages 147-173

  Antonyak, Marc A ^a   Cerione, Richard A ^a  

^a NONE

Author keywords

Angiogenesis; ARF6; Cytoskeleton; EGF receptor; Exosomes; Extracellular matrix; Intercellular communication; Metastasis; Microparticles; Microvesicles; Oncosomes; RhoA; Shedding vesicles; Tumor microenvironment

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 6; EPIDERMAL GROWTH FACTOR RECEPTOR; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANGIOGENESIS; ARTICLE; CANCER CELL; CELL COMMUNICATION; CELL VACUOLE; CONTROLLED STUDY; CYTOSKELETON; ENDOCYTOSIS; EXOSOME; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; TUMOR MICROENVIRONMENT; ANIMAL; DISEASE COURSE; MEMBRANE MICROPARTICLE; METABOLISM; NEOPLASMS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; VASCULARIZATION;

ANIMALS; CELL COMMUNICATION; CELL-DERIVED MICROPARTICLES; DISEASE PROGRESSION; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84910090666     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-0856-1_11     Document Type: Article

References (137)

1. Baraniak PR, McDevitt TC (2010) Stem cell paracrine actions and tissue regeneration. Regen Med 5:121-143
2. Perrimon N, Pitsouli C, Shilo BZ (2012) Signaling mechanisms controlling cell fate and embryonic patterning. Cold Spring Harb Perspect Biol 4:a005975
3. Wilson KJ, Mill C, Lambert S et al (2012) EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling. Growth Factors 30:107-116
4. Seshacharyulu P, Ponnusamy MP, Haridas D et al (2012) Targeting the EGFR signaling pathway in cancer therapy. Expert Opin Ther Targets 16:15-31
5. Shilo BZ (2005) Regulating the dynamics of EGF receptor signaling in space and time. Development 132:4017-4027
6. Han W, Lo HW (2012) Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations. Cancer Lett 318: 124-134
7. Hopkins S, Linderoth E, Hantschel O et al (2012) Mig6 is a sensor of EGF receptor inac-tivation that directly activates c-Abl to induce apoptosis during epithelial homeostasis. Dev Cell 23:547-559
8. Moscatello DK, Montgomery RB, Sundareshan P et al (1996) Transformational and altered signal transduction by a naturally occurring mutant EGF receptor. Oncogene 13:85-96
9. Moscatello DK, Ramirez G, Wong AJ (1997) A naturally occurring mutant human epidermal growth factor receptor as a target for peptide vaccine immunotherapy of tumors. Cancer Res 57:1419-1424
10. Miettinen PJ, Berger JE, Meneses J et al (1995) Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 376:337-341
11. Miettinen PJ, Chin JR, Shum L et al (1999) Epidermal growth factor receptor function is necessary for normal craniofacial development and palate closure. Nat Genet 22:69-73
12. Threadgill DW, Dlugosz AA, Hansen LA et al (1995) Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269:230-234
13. Kramer C, Klasmeyer K, Bojar H et al (2007) Heparin-binding epidermal growth factorlike growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome. Cancer 109:2016-2024
14. Moscatello DK, Holgado-Madruga M, Godwin AK et al (1995) Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. Cancer Res 55: 5536-5539
15. Paez JG, Janne PA, Lee JC et al (2004) EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304:1497-1500
16. Verhaak RG, Hoadley KA, Purdom E et al (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98-110
17. Antonyak MA, Kenyon LC, Godwin AK et al (2002) Elevated JNK activation contributes to the pathogenesis of human brain tumors. Oncogene 21:5038-5046
18. Boroughs LK, Antonyak MA, Johnson JL et al (2011) A unique role for heat shock protein 70 and its binding partner tissue transglutaminase in cancer cell migration. J Biol Chem 286:37094-37107
19. Antonyak MA, Wilson KF, Cerione RA (2012) R(h)oads to microvesicles. Small GTPases 3: 219-224
20. Al-Nedawi K, Meehan B, Rak J (2009) Microvesicles: messengers and mediators of tumor progression. Cell Cycle 8:2014-2018
21. Cocucci E, Meldolesi J (2011) Ectosomes. Curr Biol 21:R940-R941
22. D’Souza-Schorey C, Clancy JW (2012) Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev 26:1287-1299
23. Cocucci E, Racchetti G, Meldolesi J (2009) Shedding microvesicles: artefacts no more. Trends Cell Biol 19:43-51
24. Di Vizio D, Kim J, Hager MH et al (2009) Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. Cancer Res 69:5601-5609
25. Varon D, Shai E (2009) Role of plateletderived microparticles in angiogenesis and tumor progression. Discov Med 8:237-241
26. Skog J, Wurdinger T, van Rijn S et al (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10:1470-1476
27. Al-Nedawi K, Meehan B, Micallef J et al (2008) Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol 10: 619-624
28. Al-Nedawi K, Meehan B, Kerbel RS et al (2009) Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci U S A 106:3794-3799
29. van der Vos KE, Balaj L, Skog J et al (2011) Brain tumor microvesicles: insights into intercellular communication in the nervous system. Cell Mol Neurobiol 31:949-959
30. Wysoczynski M, Ratajczak MZ (2009) Lung cancer secreted microvesicles: underappreciated modulators of microenvironment in expanding tumors. Int J Cancer 125: 1595-1603
31. Antonyak MA, Li B, Boroughs LK et al (2011) Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fi bronectin to recipient cells. Proc Natl Acad Sci U S A 108: 4852-4857
32. Tian T, Wang Y, Wang H et al (2010) Visualizing of the cellular uptake and intracellular traffi cking of exosomes by live-cell microscopy. J Cell Biochem 111:488-496
33. Rak J (2010) Microparticles in cancer. Semin Thromb Hemost 36:888-906
34. Ge R, Tan E, Sharghi-Namini S et al (2012) Exosomes in cancer microenvironment and beyond: have we overlooked these extracellular messengers? Cancer Microenviron 5:323-332
35. Di Vizio D, Morello M, Dudley AC et al (2012) Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease. Am J Pathol 181: 1573-1584
36. Ginestra A, La Placa MD, Saladino F et al (1998) The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness. Anticancer Res 18:3433-3437
37. Mathivanan S, Ji H, Simpson RJ (2010) Exosomes: extracellular organelles important in intercellular communication. J Proteomics 73:1907-1920
38. Teis D, Saksena S, Emr SD (2009) SnapShot: the ESCRT machinery. Cell 137:182-182 e181
39. Ceruti S, Colombo L, Magni G et al (2011) Oxygen-glucose deprivation increases the enzymatic activity and the microvesiclemediated release of ectonucleotidases in the cells composing the blood-brain barrier. Neurochem Int 59:259-271
40. Hanson PI, Cashikar A (2012) Multivesicular body morphogenesis. Annu Rev Cell Dev Biol 28:337-362
41. Piccin A, Murphy WG, Smith OP (2007) Circulating microparticles: pathophysiology and clinical implications. Blood Rev 21:157-171
42. Muralidharan-Chari V, Clancy JW, Sedgwick A et al (2010) Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 123:1603-1611
43. Muralidharan-Chari V, Clancy J, Plou C et al (2009) ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol 19:1875-1885
44. Hosseini-Beheshti E, Pham S, Adomat H et al (2012) Exosomes as biomarker enriched microvesicles: characterization of exosomal proteins derived from a panel of prostate cell lines with distinct AR phenotypes. Mol Cell Proteomics 11:863-885
45. Li B, Antonyak MA, Zhang J et al (2012) RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells. Oncogene 31:4740-4749
46. Scott G (2012) Demonstration of melanosome transfer by a shedding microvesicle mechanism. J Invest Dermatol 132:1073-1074
47. Shen B, Wu N, Yang JM et al (2011) Protein targeting to exosomes/microvesicles by plasma membrane anchors. J Biol Chem 286: 14383-14395
48. Balaj L, Lessard R, Dai L et al (2011) Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun 2:180
49. Choi DS, Lee JM, Park GW et al (2007) Proteomic analysis of microvesicles derived from human colorectal cancer cells. J Proteome Res 6:4646-4655
50. Gallo A, Tandon M, Alevizos I et al (2012) The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One 7:e30679
51. Graner MW, Alzate O, Dechkovskaia AM et al (2009) Proteomic and immunologic analyses of brain tumor exosomes. FASEB J 23:1541-1557
52. Grange C, Tapparo M, Collino F et al (2011) Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res 71:5346-5356
53. Noerholm M, Balaj L, Limperg T et al (2012) RNA expression patterns in serum microvesi-cles from patients with glioblastoma multiforme and controls. BMC Cancer 12:22
54. Zhuang G, Wu X, Jiang Z et al (2012) Tumour-secreted miR-9 promotes endothe-lial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J 31:3513-3523
55. Baran J, Baj-Krzyworzeka M, Weglarczyk K et al (2010) Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunol Immunother 59: 841-850
56. Marcucci G, Mrozek K, Radmacher MD et al (2009) MicroRNA expression profiling in acute myeloid and chronic lymphocytic leukaemias. Best Pract Res Clin Haematol 22:239-248
57. Sandvig K, Llorente A (2012) Proteomic analysis of microvesicles released by the human prostate cancer cell line PC-3. Mol Cell Proteomics 11:M111.012914
58. Zhou Q, Souba WW, Croce CM et al (2010) MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome. Gut 59:775-784
59. Del Conde I, Bharwani LD, Dietzen DJ et al (2007) Microvesicle-associated tissue factor and Trousseau's syndrome. J Thromb Haemost 5:70-74
60. Graves LE, Ariztia EV, Navari JR et al (2004) Preinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res 64:7045-7049
61. Chen C, Skog J, Hsu CH et al (2010) Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab Chip 10: 505-511
62. Owen DM, Magenau A, Williamson D et al (2012) The lipid raft hypothesis revisited: new insights on raft composition and function from super-resolution fluorescence microscopy. Bioessays 34:739-747
63. Simons K, Ikonen E (1997) Functional rafts in cell membranes. Nature 387:569-572
64. Gangalum RK, Atanasov IC, Zhou ZH et al (2011) AlphaB-crystallin is found in detergent-resistant membrane microdomains and is secreted via exosomes from human retinal pigment epithelial cells. J Biol Chem 286: 3261-3269
65. Lopez JA, del Conde I, Shrimpton CN (2005) Receptors, rafts, and microvesicles in thrombosis and inflammation. J Thromb Haemost 3:1737-1744
66. Mairhofer M, Steiner M, Mosgoeller W et al (2002) Stomatin is a major lipid-raft component of platelet alpha granules. Blood 100: 897-904
67. Del Conde I, Shrimpton CN, Thiagarajan P et al (2005) Tissue-factor-bearing microvesi-cles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106:1604-1611
68. Liu ML, Scalia R, Mehta JL et al (2012) Cholesterol-induced membrane microvesi-cles as novel carriers of damage-associated molecular patterns: mechanisms of formation, action, and detoxification. Arterioscler Thromb Vasc Biol 32:2113-2121
69. Pomorski T, Menon AK (2006) Lipid flip-pases and their biological functions. Cell Mol Life Sci 63:2908-2921
70. Seigneuret M, Devaux PF (1984) ATP-dependent asymmetric distribution of spinlabeled phospholipids in the erythrocyte membrane: relation to shape changes. Proc Natl Acad Sci U S A 81:3751-3755
71. Contreras FX, Sanchez-Magraner L, Alonso A et al (2010) Transbilayer (flip-flop) lipid motion and lipid scrambling in membranes. FEBS Lett 584:1779-1786
72. Dasgupta SK, Abdel-Monem H, Niravath P et al (2009) Lactadherin and clearance of platelet-derived microvesicles. Blood 113: 1332-1339
73. Lima LG, Chammas R Monteiro RQ et al (2009) Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner. Cancer Lett 283:168-175
74. Collino F, Deregibus MC, Bruno S et al (2010) Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One 5:e11803
75. Meng Y, Kang S, Fishman DA (2005) Lysophosphatidic acid stimulates fas ligand microvesicle release from ovarian cancer cells. Cancer Immunol Immunother 54:807-814
76. Charras GT, Hu CK, Coughlin M et al (2006) Reassembly of contractile actin cortex in cell blebs. J Cell Biol 175:477-490
77. Fackler OT, Grosse R (2008) Cell motility through plasma membrane blebbing. J Cell Biol 181:879-884
78. Heasman SJ, Ridley AJ (2008) Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat Rev Mol Cell Biol 9:690-701
79. Sahai E (2007) Illuminating the metastatic process. Nat Rev Cancer 7:737-749
80. Hahmann C, Schroeter T (2010) Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity. Cell Mol Life Sci 67: 171-177
81. Mizuno K (2013) Signaling mechanisms and functional roles of cofilin phosphory-lation and dephosphorylation. Cell Signal 25: 457-469
82. Narumiya S, Ishizaki T, Uehata M (2000) Use and properties of ROCK-specific inhibitor Y-27632. Methods Enzymol 325:273-284
83. Narumiya S, Tanji M, Ishizaki T (2009) Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. Cancer Metastasis Rev 28:65-76
84. Sahai E, Ishizaki T, Narumiya S et al (1999) Transformation mediated by RhoA requires activity of ROCK kinases. Curr Biol 9:136-145
85. Del Vecchio CA, Li G, Wong AJ (2012) Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas. Expert Rev Vaccines 11:133-144
86. Corcoran C, Rani S, O'Brien K et al (2012) Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes. PLoS One 7:e50999
87. Lehmann BD, Paine MS, Brooks AM et al (2008) Senescence-associated exosome release from human prostate cancer cells. Cancer Res 68:7864-7871
88. Shedden K, Xie XT, Chandaroy P et al (2003) Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res 63:4331-4337
89. Svensson KJ, Kucharzewska P, Christianson HC et al (2011) Hypoxia triggers a proangio-genic pathway involving cancer cell microves-icles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells. Proc Natl Acad Sci U S A 108:13147-13152
90. Erickson JW, Cerione RA (2010) Glutaminase: a hot spot for regulation of cancer cell metabolism? Oncotarget 1:734-740
91. Koppenol WH, Bounds PL, Dang CV (2011) Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 11:325-337
92. Wilson KF, Erickson JW, Antonyak MA et al (2013) Rho GTPases and their roles in cancer metabolism. Trends Mol Med 19:74-82
93. Altieri DC (2008) New wirings in the sur-vivin networks. Oncogene 27:6276-6284
94. Cheung CH, Cheng L, Chang KY et al (2011) Investigations of survivin: the past, present and future. Front Biosci 16:952-961
95. Honegger A, Leitz J, Bulkescher J et al (2013) Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and amounts of extracellular microvesicles released from HPV-positive cancer cells. Int J Cancer 133:1631-1642. doi:10.1002/ijc.28164
96. Khan S, Jutzy JM, Aspe JR et al (2011) Survivin is released from cancer cells via exo-somes. Apoptosis 16:1-12
97. Khan S, Jutzy JM, Valenzuela MM et al (2012) Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer. PLoS One 7:e46737
98. Taylor DD, Gercel-Taylor C, Parker LP (2009) Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer. Gynecol Oncol 115:112-120
99. Fujita M, Kinoshita T (2012) GPI-anchor remodeling: potential functions of GPI-anchors in intracellular trafficking and membrane dynamics. Biochim Biophys Acta 1821: 1050-1058
100. Muller G, Schneider M, Biemer-Daub G et al (2011) Microvesicles released from rat adi-pocytes and harboring glycosylphosphati-dylinositol-anchored proteins transfer RNA stimulating lipid synthesis. Cell Signal 23: 1207-1223
101. Hao S, Ye Z, Li F et al (2006) Epigenetic transfer of metastatic activity by uptake of highly metastatic B16 melanoma cell-released exosomes. Exp Oncol 28:126-131
102. Hessvik NP, Phuyal S, Brech A et al (2012) Profiling of microRNAs in exosomes released from PC-3 prostate cancer cells. Biochim Biophys Acta 1819:1154-1163
103. Chiba M, Kimura M, Asari S (2012) Exosomes secreted from human colorectal cancer cell lines contain mRNAs, microRNAs and natural antisense RNAs, that can transfer into the human hepatoma HepG2 and lung cancer A549 cell lines. Oncol Rep 28:1551-1558
104. Bolukbasi MF, Mizrak A, Ozdener GB et al (2012) miR-1289 and "Zipcode"-like sequence enrich mRNAs in microvesicles. Mol Ther Nucleic Acids 1:e10
105. Faini M, Beck R, Wieland FT et al (2013) Vesicle coats: structure, function, and general principles of assembly. Trends Cell Biol 23:279-288. doi:10.1016/j.tcb.2013.01.005
106. Donaldson JG, Jackson CL (2011) ARF family G proteins and their regulators: roles in membrane transport, development and disease. Nat Rev Mol Cell Biol 12:362-375
107. Martins VR Dias MS, Hainaut P (2013) Tumor-cell-derived microvesicles as carriers of molecular information in cancer. Curr Opin Oncol 25:66-75
108. Egeblad M, Nakasone ES, Werb Z (2010) Tumors as organs: complex tissues that interface with the entire organism. Dev Cell 18: 884-901
109. Bhowmick NA, Neilson EG, Moses HL (2004) Stromal fibroblasts in cancer initiation and progression. Nature 432:332-337
110. Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406:747-752
111. Greaves M, Maley CC (2012) Clonal evolution in cancer. Nature 481:306-313
112. Redmond KM, Wilson TR, Johnston PG et al (2008) Resistance mechanisms to cancer chemotherapy. Front Biosci 13:5138-5154
113. Roberts PJ, Der CJ (2007) Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26:3291-3310
114. Campanella C, Bucchieri F, Merendino AM et al (2012) The odyssey of Hsp60 from tumor cells to other destinations includes plasma membrane-associated stages and Golgi and exosomal protein-trafficking modalities. PLoS One 7:e42008
115. Chalmin F, Ladoire S, Mignot G et al (2010) Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Invest 120:457-471
116. McCready J, Sims JD, Chan D et al (2010) Secretion of extracellular hsp90alpha via exosomes increases cancer cell motility: a role for plasminogen activation. BMC Cancer 10:294
117. Morimoto RI (2011) The heat shock response: systems biology of proteotoxic stress in aging and disease. Cold Spring Harb Symp Quant Biol 76:91-99
118. Rappa F, Farina F, Zummo G et al (2012) HSP-molecular chaperones in cancer biogenesis and tumor therapy: an overview. Anticancer Res 32:5139-5150
119. Safaei R, Larson BJ, Cheng TC et al (2005) Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells. Mol Cancer Ther 4:1595-1604
120. Boing AN, Hau CM, Sturk A et al (2008) Platelet microparticles contain active caspase 3. Platelets 19:96-103
121. Sapet C, Simoncini S, Loriod B et al (2006) Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2. Blood 108:1868-1876
122. Abid Hussein MN, Boing AN, Sturk A et al (2007) Inhibition of microparticle release triggers endothelial cell apoptosis and detachment. Thromb Haemost 98:1096-1107
123. Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3:401-410
124. Gialeli C, Theocharis AD, Karamanos NK (2011) Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 278:16-27
125. Dolo V, D'Ascenzo S, Violini S et al (1999) Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro. Clin Exp Metastasis 17:131-140
126. Janowska-Wieczorek A, Marquez-Curtis LA, Wysoczynski M et al (2006) Enhancing effect of platelet-derived microvesicles on the invasive potential of breast cancer cells. Transfusion 46:1199-1209
127. Janowska-Wieczorek A, Wysoczynski M, Kijowski J et al (2005) Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 113:752-760
128. Braundmeier AG, Dayger CA, Mehrotra P et al (2012) EMMPRIN is secreted by human uterine epithelial cells in microvesicles and stimulates metalloproteinase production by human uterine fibroblast cells. Reprod Sci 19:1292-1301
129. Millimaggi D, Mari M, D'Ascenzo S etal (2007) Tumor vesicle-associated CD147 modulates the angiogenic capability of endo- thelial cells. Neoplasia 9:349-357
130. Abe T, Okamura K, Ono M et al (1993) Induction of vascular endothelial tubular morphogenesis by human glioma cells. A model system for tumor angiogenesis. J Clin Invest 92:54-61
131. Baj-Krzyworzeka M, Szatanek R, Weglarczyk K et al (2006) Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol Immunother 55:808-818
132. Mause SF, Weber C (2010) Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 107:1047-1057
133. Joosse SA, Pantel K (2013) Biologic challenges in the detection of circulating tumor cells. Cancer Res 73:8-11
134. Peinado H, Aleckovic M, Lavotshkin S et al (2012) Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 18:883-891
135. Shao H, Chung J, Balaj L et al (2012) Protein typing of circulating microvesicles allows realtime monitoring of glioblastoma therapy. Nat Med 18:1835-1840
136. Aliotta JM, Pereira M, Johnson KW et al (2010) Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcription. Exp Hematol 38: 233-245
137. Nilsson J, Skog J, Nordstrand A et al (2009) Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br J Cancer 100:1603-1607